These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30050528)

  • 1. Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita.
    Koga H; Kasprick A; López R; Aulí M; Pont M; Godessart N; Zillikens D; Bieber K; Ludwig RJ; Balagué C
    Front Immunol; 2018; 9():1558. PubMed ID: 30050528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases.
    Ghorbanalipoor S; Emtenani S; Parker M; Kamaguchi M; Osterloh C; Pigors M; Gross N; Khil'chenko S; Kasprick A; Patzelt S; Wortmann D; Ibrahim IO; Izumi K; Goletz S; Boch K; Kalies K; Bieber K; Smith P; Schmidt E; Ludwig RJ
    Front Immunol; 2022; 13():865241. PubMed ID: 36248903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita.
    Koga H; Recke A; Vidarsson G; Pas HH; Jonkman MF; Hashimoto T; Kasprick A; Ghorbanalipoor S; Tenor H; Zillikens D; Ludwig RJ
    J Invest Dermatol; 2016 Nov; 136(11):2211-2220. PubMed ID: 27388992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita.
    Kovacs B; Tillmann J; Freund LC; Nimmerjahn F; Sadik CD; Bieber K; Ludwig RJ; Karsten CM; Köhl J
    Front Immunol; 2019; 10():3012. PubMed ID: 31993051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita.
    Gross N; Marketon J; Mousavi S; Kalies K; Ludwig RJ; Bieber K
    Front Immunol; 2024; 15():1343299. PubMed ID: 38799441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granzyme B inhibition reduces autoantibody-induced dermal-epidermal separation in an ex vivo model of epidermolysis bullosa acquisita.
    Emtenani S; Lebhar H; Marquis CP; Ludwig RJ; Schmidt E
    Exp Dermatol; 2024 Sep; 33(9):e15172. PubMed ID: 39219105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune mechanism-targeted treatment of experimental epidermolysis bullosa acquisita.
    Ludwig R
    Expert Rev Clin Immunol; 2015; 11(12):1365-78. PubMed ID: 26471717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model systems duplicating epidermolysis bullosa acquisita: a methodological review.
    Ludwig RJ
    Autoimmunity; 2012 Feb; 45(1):102-10. PubMed ID: 21923614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita.
    Tukaj S; Hellberg L; Ueck C; Hänsel M; Samavedam U; Zillikens D; Ludwig RJ; Laskay T; Kasperkiewicz M
    Exp Dermatol; 2015 Jun; 24(6):471-3. PubMed ID: 25739426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita.
    Zillikens H; Kasprick A; Osterloh C; Gross N; Radziewitz M; Hass C; Hartmann V; Behnen-Härer M; Ernst N; Boch K; Vidarsson G; Visser R; Laskay T; Yu X; Petersen F; Ludwig RJ; Bieber K
    Front Med (Lausanne); 2021; 8():713312. PubMed ID: 34557502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermolysis bullosa acquisita: what's new?
    Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice.
    Mihai S; Hirose M; Wang Y; Thurman JM; Holers VM; Morgan BP; Köhl J; Zillikens D; Ludwig RJ; Nimmerjahn F
    Front Immunol; 2018; 9():535. PubMed ID: 29616034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita.
    Haeger SC; Kridin K; Pieper M; Griewahn L; Nimmerjahn F; Zillikens D; König P; Ludwig RJ; Hundt JE
    Front Immunol; 2022; 13():938306. PubMed ID: 36311755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita.
    Sadeghi H; Gupta Y; Möller S; Samavedam UK; Behnen M; Kasprick A; Bieber K; Müller S; Kalies K; de Castro Marques A; Recke A; Schmidt E; Zillikens D; Laskay T; Mariani J; Ibrahim SM; Ludwig RJ
    J Pathol; 2015 Sep; 237(1):111-22. PubMed ID: 25953430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients.
    Woodley DT; Ram R; Doostan A; Bandyopadhyay P; Huang Y; Remington J; Hou Y; Keene DR; Liu Z; Chen M
    J Invest Dermatol; 2006 Jun; 126(6):1323-30. PubMed ID: 16543893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
    Hashimoto T; Ishii N; Ohata C; Furumura M
    J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitriol Treatment Ameliorates Inflammation and Blistering in Mouse Models of Epidermolysis Bullosa Acquisita.
    Tukaj S; Bieber K; Witte M; Ghorbanalipoor S; Schmidt E; Zillikens D; Ludwig RJ; Kasperkiewicz M
    J Invest Dermatol; 2018 Feb; 138(2):301-309. PubMed ID: 28942362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita.
    Iwata H; Witte M; Samavedam UK; Gupta Y; Shimizu A; Ishiko A; Schröder T; Seeger K; Dahlke M; Rades D; Zillikens D; Ludwig RJ
    J Immunol; 2015 Sep; 195(5):1945-54. PubMed ID: 26202985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
    Gammon WR; Inman AO; Wheeler CE
    J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.